• Pfizer Inc. (PFE)'s Lyrica Meets Goals in US, Europe Studies More...
• Merck & Co., Inc. (MRK) Reports Positive Isentress Data More...
• Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study More...
• OncoSec Medical Inc. OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies More...
• Orexo AB Reports Positive Feedback from Pre-NDA Meeting With FDA - Clearing Path for Regulatory Submission of OX219 More...
• Vitamin D May Protect Lung Function in Smokers, Brigham and Women's Hospital Study More...
• Mom's HIV Drugs May Pass to Baby in Womb, Breast-Feeding, University of California, San Francisco (UCSF) Study More...
• Snacking and BMI Linked to Double Effect of Brain Activity and Self-Control,University of Exeter Study More...
• Children With Trisomy 13 and 18 and Their Families Appear Happy, Sainte-Justine University Hospital Center and University Of Montreal Study More...
• Type 2 Diabetes Drug, DPP-4 Inhibitor Linagliptin, is Clinically Effective for Long-Term Use, Cardiff University''s Thirty-Two Country Trial Suggests More...
• Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking Treatment for Chronic Liver Disease With Fibrosis (Scarring) and Cirrhosis More...
• IntelliCell BioSciences (SVFC) Files Patent Application for a New Research Technique More...
• Derma Sciences, Inc. (DSCI) Announces Issuance of Two New U.S. Patents for DSC127 More...
• Amarin Corporation PLC (AMRN)'s Website Blunder Pushes Shares Higher More...
• Would Higher Severance be the Solution for Merck KGaA (MKGAF.PK) Workers? More...
• Imperial Innovations Pumps $26.5 Million into Cell Medica More...
• PTC Therapeutics, Inc. Closes $30 Million Financing More...
• Chiasma Inc. Closes $38.5 Million Equity Financing More...
• Alexza Pharmaceuticals, Inc. (ALXA) Secures a $20 Million Committed Equity Financing Facility With Azimuth Opportunity, L.P. More...
• Fresenius Kabi AG Buys Fenwal for $1.1 Billion More...
• Boehringer Ingelheim Corporation Buys Funxional Therapeutics Ltd.'s Phase II Respiratory Drug Program More...
• Synergy Pharmaceuticals Signs Definitive Agreement to Acquire Callisto Pharmaceuticals More...
• Sandoz Completes Acquisition of Fougera (AAA), Positioning Sandoz as #1 in Generic Dermatology Globally More...
• Medline Industries, Inc. Acquires Parts of Personal Hygiene Business From Perrigo Company (PRGO) More...
• Basilea Pharmaceutica (BSLN.SW) Announces Completion of Toctino(R) (alitretinoin) Transaction With Stiefel Laboratories More...
• Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications More...
• Wuhan Institute of Biological Products and Refine Technology Collaborate on Vaccines More...
• IFPMA, Biotechnology Industry Organization (BIO) and WADA Advance Anti-Doping Collaboration With the Launch of 2 FIELDS 1 GOAL Campaign More...
• Caisson Biotech, LLC Appoints Biotechnology VeteranGlenn Nedwin CEO and President More...
• BREG, Inc. Appoints Former Integra LifeSciences Corporation (IART) CEO as Chairman of the Board More...
• Pacific Biosciences Names David Botstein, Ph.D. to Its Board of Directors More...
• InterMune, Inc. (ITMN) Reports Second Quarter 2012 Financial Results and Business Highlights More...
• Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2012 Financial Results Conference Call More...
• Mentor Capital Cancer Immunotherapy Index Gains 29% During First Half of 2012 More...
• Pfizer Inc. (PFE) Loses Prempro Ruling, Must Pay $10.4 Million More...
• Illumina, Inc. (ILMN) Countersues Intelligent Bio-Systems and QIAGEN N.V. (QGEN) for Patent Infringement More...
Via PaidContent: The Department of Justice announced today that it will keep as-is the settlement it imposed on Apple and five publishers in a hotly debated legal standoff involving the pricing of e-books. After a series of investigations, in the spring of this year, the DOJ filed an anti-trust case against Apple and five publishers for uncompetitively setting the price of e-books too high. The motion drew out an extensive backlash from Apple and its publishing partners, with some, like the Authors Guild, arguing that the settlement would further increase Amazon's existing dominance in the e-book selling space. The anti-DOJ sentiments grew to include political voices like New York senator Chuck Schumer, who vented his disapproval in a Wall Street Journal opinion column in mid-June. The DOJ today published a document addressing the 868 public comments it recieved in response to the settlement, saying that it wouldn't budge.
Is Amazon Making A 10-inch Tablet?
Amazon is getting ready to introduce new tablets, Staples' president of U.S. retail, Demos Parneros, told Reuters Monday.
Parneros said the online retailer will introduce five or six new tablet SKUs, or stock-keeping units, including those for a 10-inch tablet model. That's not necessarily the same as five or six new tablets because each version of a device gets its own SKU. The 16GB iPhone 4s, for instance, has a different SKU than the 32GB iPhone 4s.
As Amazon's line of E Ink Kindles has proved, hardware is a good vehicle for selling content. A hit tablet could help Amazon gain market share in electronically delivered music and video in the same way its Kindles have helped establish the company as a leading distributor of ebooks.
That's why moving further into the hardware business makes sense for Amazon. But can Amazon, which released its first Kindle just five years ago, continue to compete with veterans like Apple and Samsung on their turf? So far no company has been able to shake the iPad's dominance over the market, but the hotter race for tablet makers is the No. 2 spot, and as of May the Kindle Fire had snagged more than half of the Android market.
Rumors have predicted Amazon's next hardware release will embody everything from a thinner Kindle Fire 2 to a smartphone that competes with Apple's iPhone. The company may divulge more during a second-quarter earnings call planned for Thursday.
Facebook Invests Record Amount In Lobbyists
Second quarter 2012 lobbying figures have been announced—and there's big news for the tech sector: Facebook announced their highest Washington spending records in history.
According to the National Journal's Josh Smith, Facebook and Google are embracing lobbying to a never-before-seen degree. Facebook spent $960,000 on lobbyists between April and June 2012, while Google spent $3.9 million. This is an all-time high for Facebook, and a large amount for Google--though not as much as they spent fighting SOPA in 2011.
Despite the new CISPA bill weaving its way through Congress that has the internet civil liberty crowd up in arms, Google hasn't lobbied against it much. However, Facebook has been actively investing in lobbying efforts related to their massive customer database and overseas expansion. For context, Fortune's Philip Elmer-DeWitt notes that Google outspent Apple on lobbying nearly 10-1.
iZettle Card Reader Begins Beta Tests Of An Android App
iZettle, a two-year old Swedish company called the "Square of Europe" is launching an Android app in beta to follow its iOS model already out in the wild. iZettle's beta test is in partnership with Samsung, and accessed through an app in Samsung's Apps store. Though it is currently only available for Samsung Galaxy models and the Samsung Note in Sweden, iZettle says they are working on extending the Android compatibility beyond Sweden, and beyond Samsung's phones. Like the Square reader, the iZettle dongle reads credit card information for a smartphone, but, as TheNextWeb explains, the tech inside can read data off the highly secure chip found in most European cards, rather than access the old-fashioned magnetic strip data that Square uses. iZettle has been expanding across northern Europe, with a pilot program launched in the U.K. in May.
Twitter And NBC Universal Partner Up To Cover The Olympics
Twitter is joining forces with NBC Universal to report events from the Olympics. An extensively curated collection of tweets from athletes (and their families), fans, and NBC reporters, will be funnelled onto NBC's Olympics coverage home page, the Wall Street Journal reports, with Twitter being labelled as the "official narrator" for live Olympic events. A member of Twitter's tweet herding squad will also join NBC's social media team. Twitter's coverage will add to the Olympics content NBC is already collecting via its new deal with Facebook and through another deal with social media discovery engine Shazam. For Twitter, the partnership with NBC will help restake its claim to be the top spot for social media chatter around broadcast TV--a position that was being, some argued, threatened by the NBC-Facebook deal. Also, as the Journal points out, the high-profile event could help Twitter establish a broader following and help it make money through the ad partnerships it has in place.
Amazon Opening London Office For Digital Streaming TV
Amazon has bought an 8-floor, 47,000 square-foot office in London in an area dubbed "TechCity" and "Silicon Roundabout" because of its density of high-tech enterprises and startups. The building will be home for the firm's Digital Media Development center, and Amazon notes that Britain has been in the lead for on-demand streaming rental of movies and TV content over the Net. Amazon's current LoveFilm and Pushbutton streaming services will be moved to the building, and then more staff will be hired to push Amazon's efforts onward. Local rival BSkyB last week unveiled its digital download service NowTV and reported increased profits. Meanwhile the BBC's iPlayer, arguably among the boldest international moves to promote streaming TV, achieved one million international downloads last week.
Spanish, Greek woes compound worries over euro
While Spanish bonds weakened for a second day and Catalonia added its name to the list of regions requiring a Spanish government bailout, fears mounted over a possible Greek exit from the euro as international creditors prepared to meet in Athens. Compounding worries were remarks by German Vice Chancellor Philipp Roesler that Greece's prospective departure from the common currency "long ago lost its terror." The growing anxieties helped send the euro to new lows against the dollar.
Bundesbank sees mixed future for German economy
Moderate growth in the latest quarter and a cloudy picture moving forward have led the Bundesbank to temper its forecast for the German economy. "The outlook for further economic development is marked by great uncertainty," the central bank said in its monthly report. Germany's Ifo business-sentiment indicator last month fell to its lowest level in two years.
Eurozone crisis hits British manufacturing hard
The eurozone crisis is taking a heavy toll in British manufacturing, which is forecast to contract 0.3% this year while the overall British economy posts 0.2% growth, according to the manufacturers organization EEF. Looking ahead, the EEF said an exit of even one country from the eurozone would deal a severe blow to future British output.
Japan continues to see modest recovery, though clouds gather abroad
With indications of further trouble in the Chinese and U.S. economies, the danger to the Japanese economy is growing, the government's Cabinet Office says in its latest report. Nonetheless, further reconstruction efforts and strong consumer spending domestically continue to fuel a moderate recovery, the office said.
Market Activities
Euro fears drive U.S. Treasury bonds to record-low yield
Investors rushed to the safety of U.S. Treasury bonds Monday as fears grew over the crisis in the eurozone. The frenzy pushed yields on 30-year U.S. Treasurys to a record-low 2.476%.
INTERNATIONAL MARKETS OVERVIEW
European stocks took a broad hit Monday as worries grew over Spain's borrowing costs and the likelihood of another bailout, as well as the increasing possibility that Greece will leave the euro. The Stoxx Europe 600 index was down 2.49% for the day. The U.S. market joined in the downward trend, with the S&P 500 falling 0.89%. Here is a continuously updated list of global stock indexes.
Economic Trends & Outlook
Revenues for India's leading industries surge in years of global trouble
India's leading industries have doubled their overall revenue in the past five years even as the global economy has struggled. Leading the way over the period were metals, technology, telecom, power, refining, automobiles, banking, pharmaceuticals and finance.
Rise in food prices might prove vexing for Indian economy
India may well be in for higher food prices, with all the attendant negative implications for inflation and the nation's economy. Monsoon rains have been uneven so far, and indications are that South Asia will see extended dryness.
Australia's economy grows 3.2% over latest 12 months
Marking the 21st consecutive year of economic growth, Australia's economy expanded 3.2% in the year ended last month, according to the Deloitte Access Economics Business Outlook. Separately, on the inflation front, Australia's central bank is expected to report a rate Wednesday that's below its target range.
Taiwan reports a decline in industrial output
Citing the problematic global economy, Taiwan's Ministry of Economic Affairs reported that the industrial output index edged back 2.44% to 128.59 last month. The steepest declines were recorded in the machinery equipment, computer, electronics and optical product sectors, noted Lin Lee-jen, director of the ministry's statistics department.
China's property market heats up again
New danger signs are emerging in China's housing market, with 25 cities seeing price gains last month out of the 70 monitored by the Chinese Academy of Social Sciences, up from just six in May. Looking ahead, "the top priority is to change the market expectation," the CASS report said, urging better regulatory measures.
South Korean finance minister warns to prepare for the worst
South Korea's finance minister warns that the country should prepare for the worst as the euro crisis drags out but says more-efficient spending and improvements in the tax system should suffice. "To improve our financial soundness, we must make sure not even a penny is wasted while building up enough means to spare in case of a crisis," Bahk Jae-wan told a government committee on fiscal management.
Myanmar, Thailand reach broad development accords
Accelerated development of a special economic zone in Dawei, Myanmar, is part of a series of cooperation agreements reached between Myanmar and Thailand in a meeting between the two countries' leaders. Memorandums on technical cooperation and economic development were also signed that should mean "consumer goods and capital goods will soon be freely transported without tax barriers," observed Somjai Phagaphasvivat, an independent academic on economics and finance.
A youthful Southeast Asia takes spotlight from rest of region
Low wages and, above all, youth are increasingly luring major investment from Asia's leading but aging economies to the Philippines and other developing nations in Southeast Asia, and booms in consumer and property markets in the region are following. "The demographic dividend is over for Japan and Korea, and it will be over for China soon. It's happening now in the ASEAN area, and it will continue for some time," observed Yoshimasa Maruyama, chief economist at Itochu.
Capital Markets & Financial Products
China mutual fund profits rise, QDII funds post loss for 2nd quarter
The second quarter saw a significant improvement for China's mutual fund industry, with profits up 63% across 1,003 funds. However, QDII funds posted losses of 4.1 billion yuan for the period, reversing profits of 5.1 billion yuan in the first quarter.
In record deal for China, Cnooc agrees to acquire Canada's Nexen
In what would be China's biggest foreign acquisition to date, the state-controlled Cnooc oil company has agreed to acquire Nexen, a Canadian energy producer, for $15.1 billion. The deal, if approved, would give Cnooc key abilities in the complex energy field of shale gas and oil sands.
Indonesia taps yuan bonds to diversify its reserves
With an uncertain short-term outlook for the euro and long-term outlook for the U.S. dollar, Indonesia has become the latest country to buy yuan-denominated bonds to diversify and strengthen its foreign-exchange reserves. The move also comes as China seeks new avenues to open up its currency for global trade and development.
Industry & Regulatory Update
Indian government likely to cap FDI in pharmaceuticals
A 49% cap on FDI ownership in the Indian pharmaceutical sector is likely to emerge as a Finance Ministry group meets today to decide on how the government should guide investment moving forward. The government has been concerned over a surge in acquisitions by foreign pharmaceutical companies and seeks to limit their influence to ensure continued access to inexpensive drugs domestically.
Ethics & Standards
JPMorgan casts doubt on suspected CD rate rigging in South Korea
JPMorgan has come to the defense of South Korean banks and brokerages suspected of manipulating interest rates on certificates of deposit. South Korea's Fair Trade Commission launched an inquiry into the allegations last week. JPMorgan says there was little potential benefit or motivation for such rigging as the suspected banks and firms have relied less on CDs for funding.
Kohli, who was initially reluctant to dance, was coaxed by Prabhu Deva to try out some intricate steps for an ad for a shoe brand. The results were so impressive that somewhere down the fun zone the duo established during their two-day shoot, the idea of a movie launch for the star-cricketer came up.
And if a source is to be believed, Kohli is not averse to the idea. Once Prabhu Deva, who according to Ram Gopal Varma is one of the three most successful Bollywood directors today after Rohit Shetty and Sajid Khan, wraps ups his current commitments, he may plan a launch for Kohli.
Prabhu Deva is currently busy with the launch of Kumar Taurani's son Girish. He is working with him for a remake of his 2005 Telugu hit 'Nuvvostanante Nenoddantana'. The original film featured Siddharth and Trisha Krishnan.
(IANS)
Apply online here
Online applications are invited from Indian nationals for direct recruitment to the post of ASSISTANT CENTRAL INTELLIGENCE OFFICER GRADE-II/EXECUTIVE.
The details of the post and its eligibility conditions are given below:-
The details of the post and its eligibility conditions are given below:-
Vacancies 750 [General- 80, OBC- 334, SC- 225, ST- 111]
Essential qualification : Graduation from a recognized university
Age limit: 27 years as of closing date of application ( date of birth
Grade-Rs.9300-34800/-plus Grade pay Rs. 4200/- plus central government allowances.
NOTE: The number of vacancies are provisional and liable to change and the post is
temporary but is likely to continue indefinitely.
* Upper age limit is relaxable by five years for SC/ST and three years for OBC candidates
Service liability: The post involves All India Transfer Liability. Therefore, the candidates
applying for the post should be ready to serve anywhere in India.
Examinations Fee:- Rs. 100/- (RUPEES ONE HUNDRED ONLY). Fee is exempted for all
Women candidates and candidates belonging to Scheduled Caste and Scheduled Tribe.
Mode of Payment:- The candidates should pay the requisite fee only through State Bank of
India Challan (Cash deposit) or on-line account with State Bank of India only (Internet Banking)
or through Debit-cum-ATM card of State Bank of India only. (Detailed information regarding
mode of payment is given on the website www.mha.nic.in )
Closing Date: 30 days from the date of publication of this advertisement in the Employment News. Therefore, on-line registration will become active from the date of publication of the advertisement till 2400 hours of the closing date (i.e., 30 days from the date of publication of the advertisement).
How to apply: (i) Applications should be submitted only through online registration by logging on to the website www.mha.nic.in
(ii) Applications will not be accepted through any other mode.
(iii) The detail instructions for online registration and other terms and conditions ot the post can be seen on the website www.mha.nic.in before applying for the post.
· General awareness
· English language
· Reasoning
· Mathematical aptitude
The exam will be consist objective and descriptive type questions. The examination for both descriptive and objective will be conducts in a single session.
It is considered discourteous to write in negative tones after any person's demise. Never speak ill of the dead, the saying goes. Journalists and writers, however, must remain faithful to their calling and document the truth about Rajesh Khanna before it is drowned in a crescendo of blandishments from publicity-hungry cronies.
Rajesh Khanna's worst enemies were the sycophants in his lifetime. They created the destructive genie which lurks within but is kept in leash by most of us. Not so with 'Kaka', as the actor was popularly known. He allowed his ego full play and, at a later date, even rued his lifestyle; but, by then, it was too late. He had alienated his well-meaning lady friends, his old schoolmates, his aides, servants and relatives.
In hindsight, the only similar example from the world of cinema I can recall was the famed Howard Hughes, inventor, industrialist, film producer, director and a psychotic. Hughes is also credited with a film which is a media favourite, a veritable study guide for young film directors. For film historians it is the greatest film ever made: Citizen Kane.
Howard Hughes introduced half a dozen girls to Hollywood, but he claimed that his best discovery was Jane Russel. After acting in a couple of films, Russell actually dumped Hughes, causing Hughes to withdraw into a private world of his own with very strict rules for all who had access to it. One former actress, Jean Peters, decided to stay with him until he died, sacrificing a promising career in Hollywood.
The only thing that separates Rajesh Khanna from Hughes is that the former contributed nothing to the industry he served while Hughes founded an entire empire of companies under the Howard Hughes Corporation which included the Trans World Airlines, Texas Equipment Co. and an armament manufacturing company. On top of everything, Hughes made stars out of ordinary men and women.
Kaka had a mean streak. He used his star power to demolish any opposition. Actress Anju Mahendroo could have much to add to my own story which I wish to share.
The time was when Rajesh Khanna was about to get married to Dimple Kapadia after a long-drawn romance with Anju Mahendroo. The latter and her mother had a royal tiff with Khanna before Mahendroo walked out of the home in which she had been a regular. The film industry was with her. What made Kaka furious was the reaction from even his well-wishers. He blamed Mahendroo and her friends for all the negative publicity.
My close friend Basu Bhattacharya had just completed his latest film "Daku" featuring Kabir Bedi and Anju Mahendroo. One working print was sent to Delhi by the producer for private screenings. The film came to me for tax exemption as I was the film expert on board the official committee of the Excise Department in the Delhi Administration.
"Daku" was based on a novelette written by the famed Punjabi writer Amrita Pritam. The writer did not charge any royalty because she had tremendous regard for Basuda as a film director. The film was issued a tax exemption for a period of one month after its first week's commercial run in Delhi. I had found the film worthy of the exemption.
The film, however, was never released.
Rajesh Khanna's fierce battle with Mahendroo led him to order the private confiscation of all films in the country featuring her. He even went so far as to declare that he would pay double the cost incurred to all filmmakers with rights over their films in which Anju Mahendroo had a role. He demanded that even lobby prints, posters, trailers and advertisement films et al featuring Mahendroo be handed to him or his representative. He paid for all the material seized.
The entire record of Mahendroo's film career to date virtually disappeared. Films already released, like "Road to Sikkim", were withdrawn. The advertisement for a well-known brand of talcum powder endorsed by Mahendroo also disappeared and, of course, there remained no trace of the film "Daku" .
Basu Bhattacharya was furious at the turn of events. "Daku" had already got full tax exemption in Punjab and more credit would be forthcoming. Kaka had other ideas. He probably had all the material destroyed. At one time Bhattacharya even contemplated re-shooting "Daku" with a new star cast, but funds were his insurmountable problem.
I think "Road To Sikkim" might still be in some private possession as a 16-mm print in eastern India. If it is still around, I would wish for it to re-surface now and its print be sent to the National Film Archives for preservation. Anju Mahendroo deserves to be resurrected.
Rajesh Khanna came to Delhi for a charity premiere I had organized for the film "Shakti" in which he played the role of a policeman. At the press meet I asked Kaka about the release of the film "Daku". His reply was that he had not heard of any such film. I told him about the Anju Mahendroo story. Khanna simply stared at me transfixed and expressed the desire to meet me separately, but I decided not to oblige him.
From time to time I am asked: Could Rajesh Khanna have been rescued?
I do think that Kaka could have been saved from himself. In 1984, Rajesh Khanna's last big hit film "Maqsad" became successful and he was in good spirits. At this time, one of his physician friends could have prevailed upon Kaka to move out of Bombay for an extended period of detoxification and recovery from his problems.
Khanna nearly succeeded in 1991. He was asked (by the Congress) to stand in a by-election for the Lok Sabha seat from New Delhi against (the Bharatiya Janata Party's) L.K. Advani . He lost by a whisker. He stood again (because Advani vacated the seat, having also won from Gandhinagar in Gujarat) against Shatrughan Sinha (also of the BJP), and won. But he wasted away his gains due to his wayward behaviour.
Rajesh Khanna's worst enemies were his arrogance and self-indulgence. He was a poor listener, always bent upon dominating the lives of his dear and loved ones. He had mood swings and could be very generous to someone at one moment and an utter miser in the next moment. The constant refrain around him touting his superstar image had turned his head and he could no longer lead a proper private life. He became consumed
by an overpowering need to be surrounded by fawning flatterers at all times.
The entire machination could well have been filmdom's clever strategy to create a counter point against the camps of Dev Anand, the aging Dilip Kumar and Raj Kapoor. The phantom created by vested interests for public consumption ultimately consumed him.
Kaka remained a lonely man. He had numerous affairs with women whom he could not marry. Dimple, foreseeing the ultimate fate of her husband, had left him to himself in his big house Ashirwad, refusing to grant him a divorce. The public never knew much about all this.
Rajesh Khanna's last supposed romance was with Devyani Chaubal, a gossip columnist cast in the mould of Hollywood's Hedda Hopper. The Khanna-Chaubal romance ended with her untimely death.
In later life Kaka also became a frequent visitor at hospitals for his many ailments caused by his erratic lifestyle. Something had to give and, in his case, it was his weak and thinning body.
Aware of Kaka's declining health, Kapadia knew that she would inherit some of his wealth as his surviving widow and share it with her daughters. Her return to Kaka in his last days could be an indication of her foresight. Many like me must feel that she rightfully deserves to inherit Rajesh Khanna's wealth after all the physical abuse she suffered from her superstar egoistic husband during the ten years of their married life.
Like Howard Hughes, Kaka did not want his illness to be made public. Both died of the same disease. Even on his deathbed, Kaka reigned over his body, come what may. The dark side of his life could eventually come to light, just as it did in the case of Howard Hughes.
( IANS)
As we know that medical sciences has been one of the toughest profession as to deal with human lives, but not in India anymore as Sweeper ( Class 4 Employees ) have been caught on camera performing the duties of doctors. It shows how cheap human lives in India as government doesn't care about people and talks big on reforms and FDI on the other hand. The flawed, corrupt malpractices in Health Care profession along with the commercialization of medical services have impaired systematic reforms at rural as well as urban areas. There have been a lot of criticism about how government dealing with health care in India as well as corrupt malpractices in Medical and Paramedical education and services, but It might take decade to change the system and make it oriented towards public health.
Few weeks ago, another shocking story regarding resistant bacterial infection ( superbugs ) spread across 40 nations from patients who got treatment in Indian Hospitals, It will dent global image of India as a country with affordable medicare and raise serious question about the healthcare industry.
Below are the three different incidents in three different hospitals of West Bengal, where class IV employees caught treating patients. Ab tak three and still counting
West Bengal, Barasat State General Hospital, a third hospital,where class IV employee treating patient,despite the presence of Doctor.
In yet another case of hospital apathy in West Bengal, a woman with a fractured leg was attended to by a grade IV non-medical staff member in the Barasat State General Hospital, despite the doctor being present at the emergency ward.
Farhana Khatun's leg was plastered by a Class IV non-medical staff member, even though Doctor SP Sardar was present at the time.
Another outsider in the room, Abdul Rafique was caught on camera removing plaster from a child's arm with a sharp knife.
A Class IV non-medical staff member of the Barasat State General hospital was seen plastering the leg of a patient.
Additionally, the patient Farhana Khatun was asked to bring in her own people to help get her plaster done.
Another Government Hospital in Ballia UP, India exposed where sweeper working as a doctor.
Few weeks ago, another shocking story regarding resistant bacterial infection ( superbugs ) spread across 40 nations from patients who got treatment in Indian Hospitals, It will dent global image of India as a country with affordable medicare and raise serious question about the healthcare industry.
Below are the three different incidents in three different hospitals of West Bengal, where class IV employees caught treating patients. Ab tak three and still counting
West Bengal, Barasat State General Hospital, a third hospital,where class IV employee treating patient,despite the presence of Doctor.
In yet another case of hospital apathy in West Bengal, a woman with a fractured leg was attended to by a grade IV non-medical staff member in the Barasat State General Hospital, despite the doctor being present at the emergency ward.
Farhana Khatun's leg was plastered by a Class IV non-medical staff member, even though Doctor SP Sardar was present at the time.
Another outsider in the room, Abdul Rafique was caught on camera removing plaster from a child's arm with a sharp knife.
A Class IV non-medical staff member of the Barasat State General hospital was seen plastering the leg of a patient.
Additionally, the patient Farhana Khatun was asked to bring in her own people to help get her plaster done.
Another Government Hospital in Ballia UP, India exposed where sweeper working as a doctor.
Uttar Pradesh's healthcare system stands exposed. After Bulandshahr, it is now a government hospital in Ballia, where a sweeper was found attending to patients in the emergency ward.
The sweeper, Rajkumar, was found administering stitches to patients in the emergency ward.
That's not all. Even the pharmacist was injecting patients. And there was no sign of a doctor anywhere.
When asked, all the Chief Medical Superintendent would say was that sweepers are not allowed to give injections, and that strict action would taken against those guilty.
"Sweepers are not allowed to treat patients. I condemn it if such practices are taking place in the Ballia Hospital," he said.
The sweeper Rajkumar, meanwhile, admitted that they administer stitches and injections to patients. And that they do it at the doctors' behest.
"I'm a sweeper at the hospital. When there are a lot of patients, I assist the doctor with stitches and injections," he says.
Clearly the cases at Ballia and Bulandhshahr may not be isolated. The fear is that UP's health services are just as bad and crumbling in other districts.
Check out the latest shocking news story from Government Hospital, Uttar Pradesh India
The poor state of healthcare services in a government hospital in Bulandshahr in Uttar Pradesh has been exposed. The hospital has 23 trained doctors but a sweeper was caught giving stitches to a patient. The video also shows a ward boy administering tetanus shots to another patient.
What's more shocking is that all this took place under the watch of the Hospital Chief Medical Officer. District health officials claim that the staff seen in the video are Operation Theatre attendants and not janitors.
Uttar Pradesh Health Minister Ahmed Hasan has now ordered a probe into the incident.
Chief Medical Officer SHS Danu said, "Sometimes there is a situation when there is nobody to attend to the patients, so they sometimes help with the distribution of medicines. I don't know whether sweepers give stitches to patients."
The incident raises certain big questions:
- Why didn't anyone stop the sweeper from treating the patient?
- Why was the Chief Medical Superintendent watching the sweeper play a doctor?
- How was a sweeper allowed to be present during treatment on the operation theatre?
- Where were the doctors when the sweeper was treating the patients?
The sweeper, Rajkumar, was found administering stitches to patients in the emergency ward.
That's not all. Even the pharmacist was injecting patients. And there was no sign of a doctor anywhere.
When asked, all the Chief Medical Superintendent would say was that sweepers are not allowed to give injections, and that strict action would taken against those guilty.
"Sweepers are not allowed to treat patients. I condemn it if such practices are taking place in the Ballia Hospital," he said.
The sweeper Rajkumar, meanwhile, admitted that they administer stitches and injections to patients. And that they do it at the doctors' behest.
"I'm a sweeper at the hospital. When there are a lot of patients, I assist the doctor with stitches and injections," he says.
Clearly the cases at Ballia and Bulandhshahr may not be isolated. The fear is that UP's health services are just as bad and crumbling in other districts.
Check out the latest shocking news story from Government Hospital, Uttar Pradesh India
The poor state of healthcare services in a government hospital in Bulandshahr in Uttar Pradesh has been exposed. The hospital has 23 trained doctors but a sweeper was caught giving stitches to a patient. The video also shows a ward boy administering tetanus shots to another patient.
What's more shocking is that all this took place under the watch of the Hospital Chief Medical Officer. District health officials claim that the staff seen in the video are Operation Theatre attendants and not janitors.
Uttar Pradesh Health Minister Ahmed Hasan has now ordered a probe into the incident.
Chief Medical Officer SHS Danu said, "Sometimes there is a situation when there is nobody to attend to the patients, so they sometimes help with the distribution of medicines. I don't know whether sweepers give stitches to patients."
The incident raises certain big questions:
- Why didn't anyone stop the sweeper from treating the patient?
- Why was the Chief Medical Superintendent watching the sweeper play a doctor?
- How was a sweeper allowed to be present during treatment on the operation theatre?
- Where were the doctors when the sweeper was treating the patients?
Update: The Chief Medical Superintendent of the Bulandshahr government hospital has defended the action saying that no janitor or sweeper administered injections as reported by the media.
The hospital CMS Shishir Kumar said, "The person in the footage is an Operation Theatre assistant and it is a part of his job to help out with this under the doctor's supervision."
He defended the incident saying that it was a case of emergency and the whole manpower had to be brought into action. "The main priority was to save lives as 11 critical patients were brought in one go after an accident," he said.
The hospital CMS Shishir Kumar said, "The person in the footage is an Operation Theatre assistant and it is a part of his job to help out with this under the doctor's supervision."
He defended the incident saying that it was a case of emergency and the whole manpower had to be brought into action. "The main priority was to save lives as 11 critical patients were brought in one go after an accident," he said.
• Roche (RHHBY) Moves Secret Heart Drug to Phase III Trial More...
• Bristol-Myers Squibb Company (BMY) Drug Fails Liver Cancer Trial More...
• EnVivo Pharmaceuticals, Inc.' Drug Helps Memory in Early Study More...
• Sanofi (France) (SAN.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody More...
• Bionor Pharma ASA's Therapeutic HIV Vaccine Vacc-4x Improves Quality of Immune Responses in HIV Patients, Resulting in Long-Term Reduction in Viral Load and Potential for Periodic "Boosts" That Could Result in New Treatment Option for People Living With HIV/AIDS More...
• Johnson & Johnson (JNJ) Recalls Some Duragesic Pain Patches More...
• Merck & Co., Inc. (MRK) May Have Solved Sleeping Pill Problem that GlaxoSmithKline (GSK), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Failed at More...
• Astex Pharmaceuticals (ASTX) Release: DACOGEN® Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia More...
• Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce Positive CHMP Opinion for Conditional Approval of ADCETRIS® (brentuximab vedotin) in Europe More...
• Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® Receives Positive CHMP Opinion for Conditional Approval in European Union More...
• First Gene Therapy in Western World From uniQure Receives Positive Opinion in Europe from CHMP More...
• Alcohol in Moderation Cuts Kidney Cancer Risk, Boston University Medical Center Study More...
• Older U.S. Women More Likely to Drink While Pregnant, Centers for Disease Control and Prevention (CDC) Study More...
• Infection With 2 HIV Strains Slows Disease Progression, Lund University Study More...
• Opiates' Side Effects Rooted in Patients' Genetics, Stanford University School of Medicine Study Shows More...
• Vitamins Helped Beat Quake Stress: University of Canterbury Study More...
• VIVUS, Inc. (VVUS) Diet Pill Patents are Questioned and Stock Sinks More...
• FDA Whistleblower Has Stirred the Pot Before More...
• Pfizer Inc. (PFE) Trips Up Generic Drugmakers' Plan for Lyrica More...
• Johnson & Johnson (JNJ) Will Pay $2.2 Billion in Risperdal Settlement More...
• Merck KGaA (MKGAF.PK) Talks With Swiss Employees Go Nowhere More...
• Nuvo Research Inc. (NRI.TO) to Receive US $6.0 Million of Milestone Payments From Pliaglis® E.U. Approvals More...
• Sunshine Biopharma, Inc. Engages Beta Pharma Canada for Manufacturing of an Initial Batch of Adva-27a More...
• The PROOF Centre of Excellence Partners with OriGene Technologieson Heart & Kidney Transplant Biomarker Program More...
• Patient Advocate Foundation and Jazz Pharmaceuticals, Inc. (JAZZ) Announce Partnership for Narcolepsy CareLine More...
• BioDiem Ltd. (BDM.AX) Signs Agreement With Royal Melbourne Institute of Technology (RMIT) to Create New Non-influenza Vaccines More...
• Supernus Pharmaceuticals (SUPN) Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer More...
• Dr. Reddy's Laboratories Ltd. (RDY)'s Net Up 28% on Generics Push More...
• Aegerion Pharmaceuticals, Inc. to Announce Second Quarter 2012 Financial Results on Wednesday, August 8 More...
• Alkermes plc (ALKS) to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2013 More...
• Anika Therapeutics (ANIK) Announces Date of Second-Quarter 2012 Financial Results Conference Call More...
• Cubist Pharmaceuticals, Inc. (CBST) Increases Revenue 30% to $231 Million in the Second Quarter More...
• DNA Genotek is Awarded Key Patent for Oral Sample System More...
The team at News.me, a mobile news app from NYC tech incubator Betaworks, says we'll see a completely rebuilt version of Digg on August 1, built out in just six weeks by their team of 10. We already knew Betaworks was going to put the News.me team to work on Digg when it announced it had acquired the social news site two weeks ago. Betaworks said it would adopt a startup like approach to its rebuild efforts, with faster development cycles. What we didn't expect was to see the team attempt to resurrect the Digg brand. For all the glory Digg claimed in the early Web 2.0 days, the brand has become so muddied that we wonder whether keeping the brand is a smart move. Then again, even winning over a fraction of the old army of fiercly loyal Diggers would be a powerful get for the next version of the site.
Facebook Buys Popular iOS, Mac Developers Acrylic
Facebook has continued its post-IPO spending spree with a purchase of popular Mac and iOS developer house Acrylic--the firm behind news aggregator Pulp and Wallet, a secure database. Both of these popular titles don't form part of the Facebook deal, but it's been noted they will receive no further development--leaving "hundreds of thousands" of users (in the company's own words), eventually, with apps that are far behind the times. Acrylic's team notes that working with Facebook represents the chance to make a "big impact in many people's lives."
After A Two-Year Delay, Kayak's IPO Soars On Its First Day Of Trading
After shaky market conditions that held up Kayak's IPO for two years, the online travel company--which debuted on the NASDAQ today at an initial price of $26 a share--hit a soaring $35 high before closing at $33.48. The good news has been a long time coming for Kayak, which first filed its intent to IPO in November 2010, when it was looking to raise $50 million. But, bit by bit, factors kept Kayak pushing the date back further and further. For one, Google closed its $700 million acquisition of travel software company ITA last April. Then Facebook's botched IPO left investors questioning the stability of Silicon Valley companies at large. But today's closing price left Kayak at a healthy $91 million raised. "Our team intends to stay focused on creating the best place to plan and book travel," the company said in a statement. "We will continue to strive to innovate and improve our technology in order to provide travelers with comprehensive, accurate and intuitive travel tools that they can access from whatever device they choose."
Good News For Gmail: Google Captures Sparrow
Gmail's notoriously limited iOS app is about to get some help from the creators of a popular alternative email app called Sparrow. Sparrow's developers, who also developed a similar email client for Mac, announced on Friday that their company has been acquired by Google.
Sparrow has a more intuitive interface than gmail's app, allowing users to complete tasks by swiping an email message or to refresh their messages by pulling down. By reducing the number of taps it takes to respond to and archive emails, the app has become known as a good tool for powering through mass amounts of email.
Gmail's app, meanwhile, has been criticized for not supporting multiple accounts, something that Sparrow has been praised for.
Though the Sparrow team will now be working on new projects with gmail, CEO Dom Leca wrote that Sparrow will remain available with support for users.
The acquisition, though good news for gmail users, is not necessarily good news for diehard Sparrow fans. An iPad app the startup teased earlier this year is now unlikely to materialize, as are any new features for its paid apps.
iTunes In The Cloud Expands To Over 35 Countries For Movies
Apple has included several more countries in the list of nations that can use its iTunes in the Cloud for movie downloads internationally, MacRumours has noticed. In total, Apple users in 154 countries have access to iTunes in the Cloud, and all of those can use the apps and Books upload and access featurea across devices. In comparison, now including the new additions, iTunes users in 38 countries can now use it for movies. (Also, 57 of 154 countries are approved to use iTunes for music, 55 have access to music video uploads, and 5 have access to TV shows.) Amazon's competing cloud service for media, Cloud Drive, is available in 27 countries.
Google Announces Steady Q2 Results
Google has posted its Q2 numbers (incidentally, via a link on its brand new Google Investor Relations Google+ page), listing revenues of $8.36 billion, 35 percent up from last year,roughly matching investors' expectations of the company. Google's international revenues added up to $5.96 billion representing 54% of its total revenues, a consistent figure since 2010. This quarter, Google's numbers included performance by fully acquired Motorola Mobility, which posted revenues of $1.25 billion and an operating loss of $233 million.
Mayer To Earn $100 Million (And Maybe Much More) From Yahoo Move
New CEO of Yahoo Marissa Mayer may be in line for around $100 million in total compensation for her move from Google. She's due for $1 million in basic salary and up to $2 million in bonuses, but an SEC filing notes that Mayer will also get around $12 million in restricted stock vesting over three years, a $30 million retention award, and an additional $30 million in stock vesting over five years, half of which is performance-related. With a few other perks--including compensation for lost income from her previous employer Google--the figure totals to around $100 million over five years. In comparison Tim Cook, new CEO of Apple, was Silicon Valley's highest paid boss in 2011 with around $378 million in total awards--Cook, however, absented himself from a potential $75 million dividend payoff earlier this year.
Our source says, "Ash has been approached by director Daniel Silva for his upcoming film that also stars Billy Zane, TV actress Sarah Khan and singer Lucky Ali." Sarah Khan confirms our story and says, "I have signed the film. I have been told the makers have approached Ash. We will start shooting in Los Angeles from September 13. It's a thriller film and I am playing Billy's wife."
Aishwarya however did not respond to our request for confirmation. The new mom, who had taken a sabbatical from Bollywood after becoming pregnant with her first child, is said to be working hard to look fit for this project.
